532 related articles for article (PubMed ID: 28122627)
21. Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes α-synuclein degradation via transcription factor EB-dependent autophagy in mutant α-synucleinA53T model of Parkinson's disease.
Mao K; Chen J; Yu H; Li H; Ren Y; Wu X; Wen Y; Zou F; Li W
Aging Cell; 2020 Jun; 19(6):e13163. PubMed ID: 32475059
[TBL] [Abstract][Full Text] [Related]
22. Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease.
Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM
Mov Disord; 2015 Oct; 30(12):1639-47. PubMed ID: 25594542
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effect of YIAEDAER peptide against Parkinson's disease like pathology in zebrafish.
Ren Q; Jiang X; Zhang S; Gao X; Paudel YN; Zhang P; Wang R; Liu K; Jin M
Biomed Pharmacother; 2022 Mar; 147():112629. PubMed ID: 35030435
[TBL] [Abstract][Full Text] [Related]
24. Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement.
Hou L; Xiong N; Liu L; Huang J; Han C; Zhang G; Li J; Xu X; Lin Z; Wang T
BMC Neurosci; 2015 Nov; 16():82. PubMed ID: 26608648
[TBL] [Abstract][Full Text] [Related]
25. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
Li B; Zhang Y; Yuan Y; Chen N
Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
[TBL] [Abstract][Full Text] [Related]
26. Targeting mitochondria for neuroprotection in Parkinson's disease.
Schapira AH
Antioxid Redox Signal; 2012 May; 16(9):965-73. PubMed ID: 22229791
[TBL] [Abstract][Full Text] [Related]
27. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease.
Kakoty V; K C S; Dubey SK; Yang CH; Taliyan R
ACS Chem Neurosci; 2021 Jul; 12(14):2643-2660. PubMed ID: 34197084
[TBL] [Abstract][Full Text] [Related]
29. Rapamycin protects against rotenone-induced apoptosis through autophagy induction.
Pan T; Rawal P; Wu Y; Xie W; Jankovic J; Le W
Neuroscience; 2009 Dec; 164(2):541-51. PubMed ID: 19682553
[TBL] [Abstract][Full Text] [Related]
30. Chaperone-mediated autophagy as a therapeutic target for Parkinson disease.
Campbell P; Morris H; Schapira A
Expert Opin Ther Targets; 2018 Oct; 22(10):823-832. PubMed ID: 30185079
[TBL] [Abstract][Full Text] [Related]
31. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
[TBL] [Abstract][Full Text] [Related]
32. Emerging preclinical pharmacological targets for Parkinson's disease.
More SV; Choi DK
Oncotarget; 2016 May; 7(20):29835-63. PubMed ID: 26988916
[TBL] [Abstract][Full Text] [Related]
33. Role of Autophagy in Parkinson's Disease.
Cerri S; Blandini F
Curr Med Chem; 2019; 26(20):3702-3718. PubMed ID: 29484979
[TBL] [Abstract][Full Text] [Related]
34. Genetic causes of Parkinson's disease and their links to autophagy regulation.
Pan PY; Yue Z
Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S154-7. PubMed ID: 24262170
[TBL] [Abstract][Full Text] [Related]
35. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
[TBL] [Abstract][Full Text] [Related]
36. Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease.
Avenali M; Blandini F; Cerri S
Front Aging Neurosci; 2020; 12():97. PubMed ID: 32372943
[TBL] [Abstract][Full Text] [Related]
37. Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson's Disease.
Rivero-Ríos P; Madero-Pérez J; Fernández B; Hilfiker S
Curr Neuropharmacol; 2016; 14(3):238-49. PubMed ID: 26517050
[TBL] [Abstract][Full Text] [Related]
38. The Interplay between Alpha-Synuclein Clearance and Spreading.
Lopes da Fonseca T; Villar-Piqué A; Outeiro TF
Biomolecules; 2015 Apr; 5(2):435-71. PubMed ID: 25874605
[TBL] [Abstract][Full Text] [Related]
39. Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism.
Limanaqi F; Biagioni F; Busceti CL; Ryskalin L; Polzella M; Frati A; Fornai F
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277285
[TBL] [Abstract][Full Text] [Related]
40. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.
Esteves AR; Gozes I; Cardoso SM
Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
